Skip to main content
Erschienen in: Neurological Sciences 3/2020

16.11.2019 | Original Article

Interictal epileptiform discharges on electroencephalography in children with methylenetetrahydrofolate reductase (MTHFR) polymorphisms

verfasst von: Elif Karatoprak, Gulhan Sozen, Kutluhan Yılmaz, Işıl Ozer

Erschienen in: Neurological Sciences | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme involved in folate metabolism. MTHFR C677T and A1298C polymorphisms are best-defined variants of MTHFR that were reported to be associated with epilepsy development. The aim of the study was to determine the incidence of interictal epileptiform discharges on electroencephalography (EEG) in asymptomatic children with C677T and A1298C polymorphisms who had no history of seizure.

Methods

Children with MTHFR C677T or A1298C polymorphisms who had normal neurological examination without a history of seizure were included in the study. Blood samples for serum folate, vitamin B12, and homocysteine levels were analyzed. Sleep and awake electroencephalograms (EEG) were recorded.

Results

A total of 102 children (50 girls and 52 boys) with a mean age of 59.4 ± 58.7 months were included in the study. Interictal epileptiform EEG discharges were detected in 3 children (2.9%).

Conclusion

There was no increase in the prevalence of interictal epileptiform discharges in seizure-free and asymptomatic children with MTHFR C677T and A1298C polymorphisms.
Literatur
1.
Zurück zum Zitat Lawrance AK, Racine J, Deng L, Wang X, Lachapelle P, Rozen R (2011) Complete deficiency of methylenetetrahydrofolate reductase in mice is associated with impaired retinal function and variable mortality, hematological profiles, and reproductive outcomes. J Inherit Metab Dis 34(1):147–157CrossRef Lawrance AK, Racine J, Deng L, Wang X, Lachapelle P, Rozen R (2011) Complete deficiency of methylenetetrahydrofolate reductase in mice is associated with impaired retinal function and variable mortality, hematological profiles, and reproductive outcomes. J Inherit Metab Dis 34(1):147–157CrossRef
2.
Zurück zum Zitat Goyette P, Christensen B, Rosenblatt DS, Rozen R (1996) Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet 59(6):1268–1275PubMedPubMedCentral Goyette P, Christensen B, Rosenblatt DS, Rozen R (1996) Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet 59(6):1268–1275PubMedPubMedCentral
3.
Zurück zum Zitat Goyette P, Frosst P, Rosenblatt DS, Rozen R (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 56(5):1052–1059PubMedPubMedCentral Goyette P, Frosst P, Rosenblatt DS, Rozen R (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 56(5):1052–1059PubMedPubMedCentral
4.
Zurück zum Zitat Watkins D, Rosenblatt DS (2012) Update and new concepts in vitamin responsive disorders of folate transport and metabolism. J Inherit Metab Dis 35(4):665–670CrossRef Watkins D, Rosenblatt DS (2012) Update and new concepts in vitamin responsive disorders of folate transport and metabolism. J Inherit Metab Dis 35(4):665–670CrossRef
5.
Zurück zum Zitat Forges T, Chery C, Audonnet S, Feillet F, Gueant JL (2010) Life-threatening methylenetetrahydrofolate reductase (MTHFR) deficiency with extremely early onset: characterization of two novel mutations in compound heterozygous patients. Mol Genet Metab 100(2):143–148CrossRef Forges T, Chery C, Audonnet S, Feillet F, Gueant JL (2010) Life-threatening methylenetetrahydrofolate reductase (MTHFR) deficiency with extremely early onset: characterization of two novel mutations in compound heterozygous patients. Mol Genet Metab 100(2):143–148CrossRef
6.
Zurück zum Zitat Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113CrossRef Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113CrossRef
7.
Zurück zum Zitat Liu R, Geng P, Ma M, Yu S, Yang M, He M, Dong Z, Zhang W (2014) MTHFR C677T polymorphism and migraine risk: a meta-analysis. J Neurol Sci 336(1–2):68–73CrossRef Liu R, Geng P, Ma M, Yu S, Yang M, He M, Dong Z, Zhang W (2014) MTHFR C677T polymorphism and migraine risk: a meta-analysis. J Neurol Sci 336(1–2):68–73CrossRef
8.
Zurück zum Zitat Mansouri L, Fekih-Mrissa N, Klai S, Mansour M, Gritli N, Mrissa R (2013) Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer’s disease. Clin Neurol Neurosurg 115(9):1693–1696CrossRef Mansouri L, Fekih-Mrissa N, Klai S, Mansour M, Gritli N, Mrissa R (2013) Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer’s disease. Clin Neurol Neurosurg 115(9):1693–1696CrossRef
9.
Zurück zum Zitat Zhu Y, Zhu RX, He ZY, Liu X, Liu HN (2015) Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson’s disease: a meta-analysis. Neurol Sci 36(6):945–951CrossRef Zhu Y, Zhu RX, He ZY, Liu X, Liu HN (2015) Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson’s disease: a meta-analysis. Neurol Sci 36(6):945–951CrossRef
10.
Zurück zum Zitat Caccamo D, Condello S, Gorgone G, Crisafulli G, Belcastro V, Gennaro S, Striano P, Pisani F, Ientile R (2004) Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. NeuroMolecular Med 6(2–3):117–126CrossRef Caccamo D, Condello S, Gorgone G, Crisafulli G, Belcastro V, Gennaro S, Striano P, Pisani F, Ientile R (2004) Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. NeuroMolecular Med 6(2–3):117–126CrossRef
11.
Zurück zum Zitat Dean JC, Robertson Z, Reid V, Wang Q, Hailey H, Moore S, Rasalam AD, Turnpenny P, Lloyd D, Shaw D, Little J (2008) A high frequency of the MTHFR 677C>T polymorphism in Scottish women with epilepsy: possible role in pathogenesis. Seizure 17(3):269–275CrossRef Dean JC, Robertson Z, Reid V, Wang Q, Hailey H, Moore S, Rasalam AD, Turnpenny P, Lloyd D, Shaw D, Little J (2008) A high frequency of the MTHFR 677C>T polymorphism in Scottish women with epilepsy: possible role in pathogenesis. Seizure 17(3):269–275CrossRef
12.
Zurück zum Zitat Rai V, Kumar P (2018) Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy. Neurol Sci 39(12):2033–2041CrossRef Rai V, Kumar P (2018) Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy. Neurol Sci 39(12):2033–2041CrossRef
13.
Zurück zum Zitat Wu YL, Yang HY, Ding XX, Zhao X, Chen J, Bi P, Sun YH (2014) Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis. Seizure 23(6):411–416 Wu YL, Yang HY, Ding XX, Zhao X, Chen J, Bi P, Sun YH (2014) Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis. Seizure 23(6):411–416
14.
Zurück zum Zitat Vilaseca MA, Moyano D, Ferrer I, Artuch R (1997) Total homocysteine in pediatric patients. Clin Chem 43(4):690–692CrossRef Vilaseca MA, Moyano D, Ferrer I, Artuch R (1997) Total homocysteine in pediatric patients. Clin Chem 43(4):690–692CrossRef
15.
Zurück zum Zitat Cavazzuti GB, Cappella L, Nalin A (1980) Longitudinal study of epileptiform EEG patterns in normal children. Epilepsia 21(1):43–55CrossRef Cavazzuti GB, Cappella L, Nalin A (1980) Longitudinal study of epileptiform EEG patterns in normal children. Epilepsia 21(1):43–55CrossRef
16.
Zurück zum Zitat Eeg-Olofsson O, Petersen I, Sellden U (1971) The development of the electroencephalogram in normal children from the age of 1 through 15 years. Paroxysmal activity, Neuropadiatrie 2(4):375–404CrossRef Eeg-Olofsson O, Petersen I, Sellden U (1971) The development of the electroencephalogram in normal children from the age of 1 through 15 years. Paroxysmal activity, Neuropadiatrie 2(4):375–404CrossRef
17.
Zurück zum Zitat Okubo Y, Matsuura M, Asai T, Asai K, Kato M, Kojima T, Toru M (1994) Epileptiform EEG discharges in healthy children: prevalence, emotional and behavioral correlates, and genetic influences. Epilepsia 35(4):832–841CrossRef Okubo Y, Matsuura M, Asai T, Asai K, Kato M, Kojima T, Toru M (1994) Epileptiform EEG discharges in healthy children: prevalence, emotional and behavioral correlates, and genetic influences. Epilepsia 35(4):832–841CrossRef
18.
Zurück zum Zitat Diaz-Arrastia R (2000) Homocysteine and neurologic disease. Arch Neurol 57(10):1422–1427CrossRef Diaz-Arrastia R (2000) Homocysteine and neurologic disease. Arch Neurol 57(10):1422–1427CrossRef
19.
Zurück zum Zitat Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26(3):137–146CrossRef Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26(3):137–146CrossRef
20.
Zurück zum Zitat Lipton SA, Kim WK, Choi YB, Kumar S, D’Emilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 94(11):5923–5928CrossRef Lipton SA, Kim WK, Choi YB, Kumar S, D’Emilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 94(11):5923–5928CrossRef
21.
Zurück zum Zitat Ono H, Sakamoto A, Mizoguchi N, Sakura N (2002) The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants. Brain Dev 24(4):223–226CrossRef Ono H, Sakamoto A, Mizoguchi N, Sakura N (2002) The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants. Brain Dev 24(4):223–226CrossRef
22.
Zurück zum Zitat Prasad AN, Rupar CA, Prasad C (2011) Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev 33(9):758–769CrossRef Prasad AN, Rupar CA, Prasad C (2011) Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev 33(9):758–769CrossRef
23.
Zurück zum Zitat Belcastro V, Gaetano G, Italiano D, Oteri G, Caccamo D, Pisani LR, Striano P, Striano S, Ientile R, Pisani F (2007) Antiepileptic drugs and MTHFR polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients. Epilepsia 48(10):1990–1994CrossRef Belcastro V, Gaetano G, Italiano D, Oteri G, Caccamo D, Pisani LR, Striano P, Striano S, Ientile R, Pisani F (2007) Antiepileptic drugs and MTHFR polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients. Epilepsia 48(10):1990–1994CrossRef
24.
Zurück zum Zitat Belcastro V, Striano P (2012) Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy. Epilepsy Res 102(1–2):1–7CrossRef Belcastro V, Striano P (2012) Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy. Epilepsy Res 102(1–2):1–7CrossRef
25.
Zurück zum Zitat van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62(5):1044–1051CrossRef van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62(5):1044–1051CrossRef
26.
Zurück zum Zitat Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM (1997) Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349(9065):1591–1593CrossRef Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM (1997) Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349(9065):1591–1593CrossRef
27.
Zurück zum Zitat van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346(8982):1070–1071CrossRef van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346(8982):1070–1071CrossRef
28.
Zurück zum Zitat Vurucu S, Demirkaya E, Kul M, Unay B, Gul D, Akin R, Gokcay E (2008) Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 32(3):844–848CrossRef Vurucu S, Demirkaya E, Kul M, Unay B, Gul D, Akin R, Gokcay E (2008) Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 32(3):844–848CrossRef
Metadaten
Titel
Interictal epileptiform discharges on electroencephalography in children with methylenetetrahydrofolate reductase (MTHFR) polymorphisms
verfasst von
Elif Karatoprak
Gulhan Sozen
Kutluhan Yılmaz
Işıl Ozer
Publikationsdatum
16.11.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 3/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04119-4

Weitere Artikel der Ausgabe 3/2020

Neurological Sciences 3/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.